Cite

HARVARD Citation

    Fumery, M. et al. (n.d.). P638 Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: a GETAID multicentre cohort study. Journal of Crohn's and colitis. p. i770. [Online]. 
  
Back to record